|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor. |
| 公司地址
| 66 Hudson Boulevard East, New York, NY, USA, 10001-2192 |
| 電話號碼
| +1 212 733-2323 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.pfizer.com |
| 員工數量
| 75000 |
| Mr. Douglas M. Lankler |
Chief Legal Officer and Executive Vice President |
-- |
26/02/2026 |
| Mr. David M. Denton |
Chief Financial Officer and Executive Vice President |
美元 1.35M |
26/02/2026 |
| Dr. Chris Boshoff, M.D.,PhD |
Chief Scientific Officer and President, Research and Development |
美元 1.20M |
26/02/2026 |
| Dr. Andrew Baum, M.D. |
Executive Vice President, Chief Strategy and Innovation Officer |
-- |
26/02/2026 |
| Ms. Lidia L. Fonseca |
Executive Vice President, Chief Digital and Technology Officer |
-- |
26/02/2026 |
| Mr. Alexandre de Germay |
Chief International Commercial Officer and Executive Vice President |
-- |
26/02/2026 |
| Mr. Michael McDermott |
Executive Vice President, Chief Global Supply and Quality Officer |
-- |
26/02/2026 |
| Mr. Aamir Malik |
Chief U.S. Commercial Officer and Executive Vice President |
美元 1.34M |
26/02/2026 |
| Ms. Payal Sahni |
Chief People Experience Officer and Executive Vice President |
-- |
26/02/2026 |
| Ms. Jennifer B. Damico |
Principal Accounting Officer, Senior Vice President and Controller |
-- |
26/02/2026 |
| Ms. Margaret M. Madden |
Senior Vice President, Corporate Secretary and Chief Governance Counsel |
-- |
26/02/2026 |
| Dr. Albert Bourla, D.V.M.,PhD |
Chairman of the Board and Chief Executive Officer |
美元 1.80M |
26/02/2026 |
|
|
| Mr. Joseph J. Echevarria |
Independent Director |
26/02/2026 |
| Mr. James Robert Quincey |
Independent Director |
26/02/2026 |
| Mr. Mortimer J. Buckley |
Independent Director |
26/02/2026 |
| Dr. Scott Gottlieb,M.D. |
Independent Director |
26/02/2026 |
| Mr. Shantanu Narayen |
Lead Independent Director |
26/02/2026 |
| Mr. Ronald E. Blaylock |
Independent Director |
26/02/2026 |
| Dr. Dan R. Littman, M.D.,PhD |
Independent Director |
26/02/2026 |
| Ms. Suzanne Nora Johnson |
Independent Director |
26/02/2026 |
| Dr. Albert Bourla, D.V.M.,PhD |
Chairman of the Board and Chief Executive Officer |
26/02/2026 |
| Mr. Cyrus Taraporevala |
Independent Director |
26/02/2026 |
| Mr. James C. Smith |
Independent Director |
26/02/2026 |
| Dr. Susan J. Hockfield, PhD |
Independent Director |
26/02/2026 |
| Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H. |
Independent Director |
26/02/2026 |
|
|
|
|
